Compare ZTS & SYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTS | SYY |
|---|---|---|
| Founded | 1952 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.7B | 40.2B |
| IPO Year | 2012 | 2003 |
| Metric | ZTS | SYY |
|---|---|---|
| Price | $116.88 | $72.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $156.20 | $87.85 |
| AVG Volume (30 Days) | 3.1M | ★ 4.7M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | 1.79% | ★ 2.95% |
| EPS Growth | ★ 10.05 | N/A |
| EPS | ★ 6.02 | 1.80 |
| Revenue | $9,467,000,000.00 | ★ $81,370,000,000.00 |
| Revenue This Year | $5.67 | $4.85 |
| Revenue Next Year | $4.85 | $4.97 |
| P/E Ratio | ★ $19.60 | $40.53 |
| Revenue Growth | 2.28 | ★ 3.20 |
| 52 Week Low | $113.30 | $67.12 |
| 52 Week High | $172.23 | $91.85 |
| Indicator | ZTS | SYY |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 31.39 |
| Support Level | $115.35 | $72.02 |
| Resistance Level | $129.28 | $77.37 |
| Average True Range (ATR) | 2.90 | 2.23 |
| MACD | 0.44 | -0.99 |
| Stochastic Oscillator | 50.60 | 27.77 |
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Sysco is the largest US foodservice distributor with 17% share of the highly fragmented $370 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (60% of fiscal 2025 revenue), education and government buildings (8%), healthcare facilities (8%), travel and leisure (7%), and other locations (17%) where individuals consume away-from-home meals. In fiscal 2025, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.